Pneumopathie interstitielle dans la polyarthrite rhumatoïde [Interstitial lung disease in rheumatoid arthritis].

Détails

ID Serval
serval:BIB_EF152D5C35B4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Pneumopathie interstitielle dans la polyarthrite rhumatoïde [Interstitial lung disease in rheumatoid arthritis].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Froidevaux-Janin S., Dudler J., Nicod L.P., Lazor R.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2011
Volume
7
Numéro
318
Pages
2272-2277
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; ReviewPublication Status: ppublish
Résumé
Interstitial lung disease (ILD) is found in up to 30% of patients with rheumatoid arthritis (RA) and is clinically manifest in 5 to 10%, resulting in significant morbidity and mortality. The most frequent histopathological forms are usual interstitial pneumonia and nonspecific interstitial pneumonia. Another recently described presentation is combined pulmonary fibrosis and emphysema. Similarly to idiopathic pulmonary fibrosis, acute exacerbation of ILD may occur in RA and is associated with severe prognosis. Smoking is a known risk factor of RA and may also play a role in the pathogenesis of RA-associated ILD, in combination with genetic and immunologic mechanisms. Several treatments of RA may also lead to drug-induced ILD.
Mots-clé
Arthritis, Rheumatoid/complications, Arthritis, Rheumatoid/diagnosis, Disease Progression, Early Diagnosis, Humans, Lung Diseases, Interstitial/complications, Lung Diseases, Interstitial/diagnosis, Models, Biological, Prognosis, Risk Factors
Pubmed
Création de la notice
31/05/2012 19:50
Dernière modification de la notice
20/08/2019 17:16
Données d'usage